Jounce Therapeutics Overview

Founded In
Organization Type
Jounce Therapeutics is dedicated to transforming the treatment of cancer. The company is discovering and developing first-in-class cancer immunotherapies designed to harness the immune system to seek out and attack cancerous cells and tumors. Jounce's proprietary product engine is driving this transformational approach, which has the potential to drive significantly more durable responses to treatment, extending and improving patients' quality of life. Founded by world leaders in immunobiology, cancer biology and clinical and translational medicine, Jounce Therapeutics was launched in 2013 with funding from leading life sciences investor, Third Rock Ventures.
Based in Cambridge, MA, Jounce Therapeutics is a small pharmaceutical company with only 137 employees and an annual revenue of $77.8M.

The Organization’s Mission

We are dedicated to transforming the treatment of cancer by developing therapies that enable the immune system to attack tumors and may bring long lasting benefit to patients.

Employee Reviews

Be the first to review!

Do you work at Jounce Therapeutics?

Help us make this company more transparent

The Team At Jounce Therapeutics

Key People

Richard Murray

Drew Pardoll

James P. Allison

Padmanee Sharma

Robert Schreiber

Thomas F. Gajewski

Louis M. Weiner

Jounce Therapeutics Rankings

Jounce Therapeutics is ranked #28 on the Best Pharmaceutical Companies to Work For in Massachusetts list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.

Read more about how we rank companies.

Jounce Therapeutics Salaries

Salary Score
Average Jounce Therapeutics Salary
$38.06 hourly
Updated March 16, 2023

Highest Paying Jobs At Jounce Therapeutics

Do you Work At Jounce Therapeutics?

Help us make this company more transparent.

Jounce Therapeutics Employment Videos

Jounce Therapeutics Financial Performance

Performance Score
We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.

How Would You Rate The Company Culture Of Jounce Therapeutics?

Have you worked at Jounce Therapeutics? Help other job seekers by rating Jounce Therapeutics.

Frequently Asked Questions about Jounce Therapeutics

When was Jounce Therapeutics founded?

Jounce Therapeutics was founded in 2013.

How many Employees does Jounce Therapeutics have?

Jounce Therapeutics has 137 employees.

How much money does Jounce Therapeutics make?

Jounce Therapeutics generates $77.8M in revenue.

What industry is Jounce Therapeutics in?

Jounce Therapeutics is in the pharmaceutical industry.

What is Jounce Therapeutics's mission?

Jounce Therapeutics's mission statement is "We are dedicated to transforming the treatment of cancer by developing therapies that enable the immune system to attack tumors and may bring long lasting benefit to patients."

What type of company is Jounce Therapeutics?

Jounce Therapeutics is a public company.

Who are Jounce Therapeutics's competitors?

Jounce Therapeutics competitors include Seagen, Eureka Therapeutics, Intracel Resources.

Who works at Jounce Therapeutics?

Richard Murray (Board Member)

Drew Pardoll (Founder)

James P. Allison (Founder)

Show More

Are You An Executive, HR Leader, Or Brand Manager At Jounce Therapeutics?

Claiming and updating your company profile on Zippia is free and easy.

Zippia gives an in-depth look into the details of Jounce Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Jounce Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Jounce Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Jounce Therapeutics. The data presented on this page does not represent the view of Jounce Therapeutics and its employees or that of Zippia.

Jounce Therapeutics may also be known as or be related to JOUNCE THERAPEUTICS INC., Jounce Therapeutics, Jounce Therapeutics Inc and Jounce Therapeutics, Inc.